Equine CD4 +CD25 high T cells exhibit regulatory activity by close contact and cytokine-dependent mechanisms in vitro

Immunology

Volumn 134, Issue 3, 2011, Pages 292-304

  Hamza, Eman ^a   Gerber, Vinzenz ^a   Steinbach, Falko ^b   Marti, Eliane ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

CD4 +CD25 + T cells; FoxP3; Horses; Suppression; Treg

Indexed keywords

CONCANAVALIN A; CYTOKINE; INTERLEUKIN 10; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL EXPANSION; COCULTURE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HORSE; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; IRRADIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HORSES; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LEUKOCYTES, MONONUCLEAR; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA1;

EID: 80053640687     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2011.03489.x     Document Type: Article

References (89)

1. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155:1151-64.
2. + regulatory T cells. Immunology 2003; 109:319-25.
3. Akdis M. Immune tolerance in allergy. Curr Opin Immunol 2009; 21:700-7.
4. Cavani A. Immune regulatory mechanisms in allergic contact dermatitis and contact sensitization. Chem Immunol Allergy 2008; 94:93-100.
5. McGee HS, Agrawal DK. Naturally occurring and inducible T-regulatory cells modulating immune response in allergic asthma. Am J Respir Crit Care Med 2009; 180:211-25.
6. Li Z, Arijs I, De Hertogh G et al. Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to Infliximab. Inflamm Bowel Dis 2010; 16:1299-310.
7. Marin ND, Paris SC, Velez VM, Rojas CA, Rojas M, Garcia LF. Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis. Tuberculosis (Edinb) 2010; 90:252-61.
8. Ogino H, Nakamura K, Ihara E, Akiho H, Takayanagi R. CD4(+)CD25(+) Regulatory T cells suppress Th17-responses in an experimental colitis model. Dig Dis Sci 2010; 56:376-86.
9. + regulatory T cells in transplantation. Am J Transplant 2009; 9:1719-24.
10. Racusen LC. T-regulatory cells in human transplantation. Am J Transplant 2008; 8:1359-60.
11. Semiletova NV, Shen XD, Baibakov B, Andakyan A. Intensity of transplant chronic rejection correlates with level of graft-infiltrating regulatory cells. J Heart Lung Transplant 2010; 29:335-41.
12. Blatner NR, Bonertz A, Beckhove P et al. In colorectal cancer mast cells contribute to systemic regulatory T-cell dysfunction. Proc Natl Acad Sci USA 2010; 107:6430-5.
13. Erdman SE, Poutahidis T. Cancer inflammation and regulatory T cells. Int J Cancer 2010; 127:768-79.
14. Wilczynski JR, Kalinka J, Radwan M. The role of T-regulatory cells in pregnancy and cancer. Front Biosci 2008; 13:2275-89.
15. Steinbach F, Deeg C, Mauel S, Wagner B. Equine immunology: offspring of the serum horse. Trends Immunol 2002; 23:223-5.
16. + immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin Immunol 2004; 16:81-8.
17. Raimondi G, Turner MS, Thomson AW, Morel PA. Naturally occurring regulatory T cells: recent insights in health and disease. Crit Rev Immunol 2007; 27:61-95.
18. Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med 2001; 193:1303-10.
19. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299:1057-61.
20. Zheng Y, Rudensky AY. Foxp3 in control of the regulatory T cell lineage. Nat Immunol 2007; 8:457-62.
21. Ziegler SF. Foxp3 of mice and men. Annu Rev Immunol 2006; 24:209-26.
22. Akdis M. T-cell tolerance to inhaled allergens: mechanisms and therapeutic approaches. Exp Opin Biol Ther 2008; 8:769-77.
23. Mittag D, Scholzen A, Varese N, Baxter L, Paukovics G, Harrison LC, Rolland JM, O'Hehir RE. The effector T cell response to ryegrass pollen is counterregulated by simultaneous induction of regulatory T cells. J Immunol 2010; 184:4708-16.
24. Commodaro AG, Peron JP, Genre J, Arslanian C, Sanches L, Muccioli C, Rizzo LV, Belfort R. IL-10 and TGF-beta immunoregulatory cytokines rather than natural regulatory T cells are associated with the resolution phase of Vogt-Koyanagi-Harada (VKH) syndrome. Scand J Immunol 2010; 72:31-7.
25. + T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J Exp Med 2002; 196:1335-46.
26. + regulatory T cells. J Immunol 2004; 172:5986-93.
27. Biller BJ, Elmslie RE, Burnett RC, Avery AC, Dow SW. Use of Foxp3 expression to identify regulatory T cells in healthy dogs and dogs with cancer. Vet Immunol Immunopathol 2007; 116:69-78.
28. Chen W, Konkel JE. TGF-beta and adaptive Foxp3(+) regulatory T cells. J Mol Cell Biol 2010; 2:30-6.
29. + T regulatory cells. J Immunol 2007; 178:4022-6.
30. Jonuleit H, Schmitt E, Kakirman H, Stassen M, Knop J, Enk AH. Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J Exp Med 2002; 196:255-60.
31. Dieckmann D, Bruett CH, Ploettner H, Lutz MB, Schuler G. Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells. J Exp Med 2002; 196:247-53.
32. + T regulatory cell-mediated suppression. Immunity 2009; 30:636-45.
33. + inhibitory hybridomas, and their cell contact dependent suppression. Immunol Res 2007; 39:62-78.
34. + suppressor T cells. Immunol Rev 2001; 182:58-67.
35. Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K, Akdis CA. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003; 33:1205-14.
36. Miyara M, Sakaguchi S. Natural regulatory T cells: mechanisms of suppression. Trends Mol Med 2007; 13:108-16.
37. Taylor A, Verhagen J, Blaser K, Akdis M, Akdis CA. Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells. Immunology 2006; 117:433-42.
38. + T cells. Nat Immunol 2007; 8:1353-62.
39. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188:287-96.
40. + regulatory T cell suppressor function. J Immunol 2009; 182:2929-38.
41. Steinbach F, Bischoff S, Freund H, Metzner-Flemisch S, Ibrahim S, Walter J, Wilke I, Mauel S. Clinical application of dendritic cells and interleukin-2 and tools to study activated T cells in horses - first results and implications for quality control. Vet Immunol Immunopathol 2009; 128:16-23.
42. Käser T, Gerner W, Hammer SE, Patzl M, Saalmuller A. Detection of Foxp3 protein expression in porcine T lymphocytes. Vet Immunol Immunopathol 2008; 125:92-101.
43. Hamza E, Doherr MG, Bertoni G, Jungi TW, Marti E. Modulation of allergy incidence in Icelandic horses is associated with a change in IL-4-producing T cells. Int Arch Allergy Immunol 2007; 144:325-37.
44. + regulatory cells from human peripheral blood express very high levels of CD25 ex vivo. Novartis Found Symp 2003; 252:67-88.
45. Käser T, Gerner W, Hammer SE, Patzl M, Saalmuller A. Phenotypic and functional characterisation of porcine CD4(+)CD25(high) regulatory T cells. Vet Immunol Immunopathol 2008; 122:153-8.
46. + regulatory T cells at the single-cell level. Eur J Immunol 2005; 35:1681-91.
47. Desjardins I, Theoret C, Joubert P, Wagner B, Lavoie JP. Comparison of TGF-beta 1 concentrations in bronchoalveolar fluid of horses affected with heaves and of normal controls. Vet Immunol Immunopathol 2004; 101:133-41.
48. Heimann M, Janda J, Sigurdardottir OG et al. Skin-infiltrating T cells and cytokine expression in Icelandic horses affected with insect bite hypersensitivity: a possible role for regulatory T cells. Vet Immunol Immunopathol 2011; 140:63-74.
49. Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T. Regulatory T cells: how do they suppress immune responses? Int Immunol 2009; 21:1105-11.
50. Hamza E, Wagner B, Jungi TW, Mirkovitch J, Marti E. Reduced incidence of insect-bite hypersensitivity in Icelandic horses is associated with a down-regulation of interleukin-4 by interleukin-10 and transforming growth factor-beta1. Vet Immunol Immunopathol 2008; 122:65-75.
51. + regulatory T cell function. Eur J Immunol 2004; 34:2480-8.
52. + regulatory T cell subsets. J Leukoc Biol 2003; 74:471-8.
53. + Foxp3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 2007; 110:2983-90.
54. Wu K, Bi Y, Sun K, Wang C. IL-10-producing type 1 regulatory T cells and allergy. Cell Mol Immunol 2007; 4:269-75.
55. Dacre KJ, McGorum BC, Marlin DJ et al. Organic dust exposure increases mast cell tryptase in bronchoalveolar lavage fluid and airway epithelium of heaves horses. Clin Exp Allergy 2007; 37:1809-18.
56. Deeg CA, Hauck SM, Amann B et al. Equine recurrent uveitis - a spontaneous horse model of uveitis. Ophthalmic Res 2008; 40:151-3.
57. Akbari O, Stock P, DeKruyff RH, Umetsu DT. Role of regulatory T cells in allergy and asthma. Curr Opin Immunol 2003; 15:627-33.
58. Bettini M, Vignali DA. Regulatory T cells and inhibitory cytokines in autoimmunity. Curr Opin Immunol 2009; 21:612-8.
59. Cavani A. T regulatory cells in contact hypersensitivity. Curr Opin Allergy Clin Immunol 2008; 8:294-8.
60. + natural T regulatory lymphocytes for clinical applications. Clin Exp Immunol 2009; 156:246-53.
61. + regulatory T cells. Nat Immunol 2003; 4:330-6.
62. + T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci USA 2009; 106:1903-8.
63. + natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006; 212:8-27.
64. Thongpan M, Kitiyakara C, Louischaroen Y, Keesukphan P, Chaiyaroj SC. Analysis of Foxp3, CD25, and CD127 expressed on regulatory T cells in Thai subjects. Asian Pac J Allergy Immunol 2009; 27:137-45.
65. - CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion. Proc Natl Acad Sci USA 2005; 102:4091-6.
66. + regulatory T cells. Exp Rev Clin Immunol 2006; 2:639-47.
67. + regulatory T cells specific for a neo-self-antigen develop at the double-positive thymic stage. Proc Natl Acad Sci USA 2006; 103:8453-8.
68. +) T cells control the production of pro-inflammatory cytokines during Plasmodium chabaudi adami infection and do not contribute to immune evasion. Int J Parasitol 2008; 38:229-38.
69. + regulatory cells from murine naive T cells. Nat Protoc 2007; 2:1789-94.
70. Pinheiro D, Singh Y, Grant CR et al. Phenotypic and functional characterization of a CD4(+) CD25(high) Foxp3(high) regulatory T-cell population in the dog. Immunology 2011; 132:111-22.
71. Garden OA, Pinheiro D, Cunningham F. All creatures great and small: regulatory T cells in mice, humans, dogs and other domestic animal species. Int Immunopharmacol 2011; 11:576-88.
72. + regulatory T cells in the human immune system. Nat Rev Immunol 2010; 10:490-500.
73. Gerner W, Stadler M, Hammer SE, Klein D, Saalmuller A. Sensitive detection of Foxp3 expression in bovine lymphocytes by flow cytometry. Vet Immunol Immunopathol 2010; 138:154-8.
74. Kuwana M. Induction of anergic and regulatory T cells by plasmacytoid dendritic cells and other dendritic cell subsets. Hum Immunol 2002; 63:1156-63.
75. Ouabed A, Hubert FX, Chabannes D, Gautreau L, Heslan M, Josien R. Differential control of T regulatory cell proliferation and suppressive activity by mature plasmacytoid versus conventional spleen dendritic cells. J Immunol 2008; 180:5862-70.
76. Kubo T, Hatton RD, Oliver J, Liu X, Elson CO, Weaver CT. Regulatory T cell suppression and anergy are differentially regulated by proinflammatory cytokines produced by TLR-activated dendritic cells. J Immunol 2004; 173:7249-58.
77. Scheffold A, Murphy KM, Hofer T. Competition for cytokines: T(reg) cells take all. Nat Immunol 2007; 8:1285-7.
78. Csencsits K, Wood SC, Lu G, Bishop DK. Transforming growth factor-beta1 gene transfer is associated with the development of regulatory cells. Am J Transplant 2005; 5:2378-84.
79. - T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 2004; 172:5149-53.
80. + regulatory T cells from human peripheral blood. J Immunol 2001; 166:7282-9.
81. - T cells into induced Tregulatory like cells. Vet Immunol Immunopathol 2010; 2:161-5.
82. +. J Exp Med 2003; 198:1875-86.
83. + T cell populations by affecting cell death: insights from modeling CFSE data. J Immunol 2007; 179:950-7.
84. Malek TR. The main function of IL-2 is to promote the development of T regulatory cells. J Leukoc Biol 2003; 74:961-5.
85. Gavin MA, Torgerson TR, Houston E et al. Single-cell analysis of normal and FoxP3-mutant human T cells: Foxp3 expression without regulatory T cell development. Proc Natl Acad Sci USA 2006; 103:6659-64.
86. Mantel PY, Ouaked N, Ruckert B, Karagiannidis C, Welz R, Blaser K, Schmidt-Weber CB. Molecular mechanisms underlying Foxp3 induction in human T cells. J Immunol 2006; 176:3593-602.
87. +. Proc Natl Acad Sci USA 2005; 102:4103-8.
88. Pillai V, Ortega SB, Wang CK, Karandikar NJ. Transient regulatory T-cells: a state attained by all activated human T-cells. Clin Immunol 2007; 123:18-29.
89. + T cells. Eur J Immunol 2007; 37:129-38.